Five-Year Update of an Expanded Phase II Study of Dose-Dense and -Intense Doxorubicin, Paclitaxel and Cyclophosphamide (ATC) in High-Risk Breast Cancer

Oncology ◽  
2005 ◽  
Vol 69 (5) ◽  
pp. 372-383 ◽  
Author(s):  
Maysa M. Abu-Khalaf ◽  
Stephen Windsor ◽  
Keita Ebisu ◽  
Saritha Salikooti ◽  
Gowri Ananthanarayanan ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Dose Dense ◽  
High Risk Breast Cancer ◽  
High Risk Breast ◽  
Risk Breast Cancer

0-29. A randomized phase II study of high-dose chemotherapy in high-risk breast cancer

The Breast ◽  
1997 ◽  
Vol 6 (4) ◽  
pp. 232-233
Author(s):  
E. Rulgers ◽  
D.J. Richel ◽  
J.W. Baars ◽  
E. van der Wall ◽  
J.H. Schornagel ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Phase Ii ◽  
Phase Ii Study ◽  
High Dose Chemotherapy ◽  
High Dose ◽  
Randomized Phase Ii ◽  
High Risk Breast Cancer ◽  
High Risk Breast ◽  
Risk Breast Cancer

scholarly journals Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy

2007 ◽  
Vol 13 (2) ◽  
pp. 488-497 ◽  
Author(s):  
Raihanatou Diallo-Danebrock ◽  
Evelyn Ting ◽  
Oleg Gluz ◽  
Alexander Herr ◽  
Svjetlana Mohrmann ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Expression Profiling ◽  
High Dose ◽  
Breast Cancer Patients ◽  
Conventional Dose ◽  
Dose Dense ◽  
High Risk Breast Cancer ◽  
High Risk Breast ◽  
Risk Breast Cancer

Long-Term Efficiency and Toxicity of Adjuvant Dose-Dense Sequential Adriamycin-Paclitaxel-Cyclophosphamide Chemotherapy in High-Risk Breast Cancer

Oncology ◽  
2010 ◽  
Vol 78 (3-4) ◽  
pp. 271-273
Author(s):  
Gyöngyi Kelemen ◽  
Gabriella Uhercsák ◽  
Katalin Ormándi ◽  
József Eller ◽  
László Thurzó ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Dose Dense ◽  
High Risk Breast Cancer ◽  
High Risk Breast ◽  
Risk Breast Cancer

Final pre-specified analysis of the phase II trial of the AE37+GM-CSF vaccine in high risk breast cancer patients to prevent recurrence.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 622-622
Author(s):  
Julia M. Greene ◽  
Erika J Schneble ◽  
Jonathan Martin ◽  
Madeline Flores ◽  
John S. Berry ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Breast Cancer Patients ◽  
Gm Csf ◽  
High Risk Breast Cancer ◽  
High Risk Breast ◽  
Risk Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document